LSEGBX
Solvonis Therapeutics plc SVNS
- Market cap
- GBP 7.8M
Key Data
- Market cap
- GBP 7.8M
- EPS
- GBP 0.00
- 52 weeks
- 0.110.39
- 1-year return
- −68.06%
- Avg. volume (200d)
- 30.7M
- Sector
- Healthcare
- Industry
- Biotechnology
Technical Signals
Technical signals
Only our Plus members can access this area.
AI Models
AI models
Only our Plus members can access this area.
About Solvonis Therapeutics Plc
Market capitalization is 7.8M GBP, earnings per share 0.00 GBP, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Biotechnology industry. The 52-week range is 0.11 – 0.39 GBX; the one-year return is −68.06%.
Frequently Asked Questions
What is the SVNS stock price today?
Price data for SVNS is temporarily unavailable and will refresh with the next update.
What are the P/E ratio and market cap of SVNS?
SVNS trades at a price-to-earnings ratio of —, with earnings per share of 0.00 GBP and a market capitalization of 7.8M GBP. Ratios use the latest reported results and the current price.
What is the 52-week range of SVNS?
Over the past 52 weeks SVNS traded between 0.11 and 0.39 GBX; the one-year return is −68.06%.
Does SVNS pay a dividend?
The current dividend yield of SVNS is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.
What sector is Solvonis Therapeutics plc in?
Solvonis Therapeutics plc (SVNS) is listed on the London Stock Exchange; its sector is Healthcare and its industry is Biotechnology.
Where does the data on this page come from and how fresh is it?
Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.